Offshoring as Tort Reform

Virginia Postrel links to an article in The Scientist:

The Serum Institute of India (SII) this week signed an agreement with the international Meningitis Vaccine Project (MVP) to develop a new conjugate meningitis A vaccine at a cost of 40 cents per dose for the African meningitis belt, which stretches from Ethiopia to Senegal.

I wonder if we can start using Indian and Chinese companies to produce the products that Americans need but which American companies are too afraid of litigation to manufacture.

This is a random, blog-thought, not developed at all> Perhaps there are still plenty of ways for Senator Edwards’s donors to promote childhood diseases, but this seems like a possible bulwark.

Posted by jk at June 30, 2004 01:42 PM